<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for GlaxoSmithKline plc - Google Finance</title>
<description>News for GlaxoSmithKline plc - Google Finance</description>
<link>http://www.google.co.uk/finance?q=LON:GSK&amp;amp;client=news-rss&amp;amp;ei=ukCXUZCsNZK40gGGswE</link>
<image>
<title>News for GlaxoSmithKline plc - Google Finance</title>
<url>/finance/s/-vLkpqn8pIU/images/logo_uk.gif</url>
<link>http://www.google.co.uk/finance?q=LON:GSK&amp;amp;client=news-rss&amp;amp;ei=ukCXUZCsNZK40gGGswE</link>
</image>
<item>
<title>Director Deals - GlaxoSmithKline PLC (GSK)</title>
<link>http://www.stockmarketwire.com/article/4597598/Director-Deals-GlaxoSmithKline-PLC-GSK.html</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:43982062800038</guid>
<pubDate>Fri, 17 May 2013 16:27:13 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.stockmarketwire.com/article/4597598/Director-Deals-GlaxoSmithKline-PLC-GSK.html&quot; style=&quot;font-size:1.2em&quot;&gt;Director Deals - GlaxoSmithKline PLC (GSK)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Stock Market Wire&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;16 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Director Deals - GlaxoSmithKline PLC (GSK). 17 May 2013 | 17:20pm. StockMarketWire.com - Andrew Witty, Chief Executive Officer, has transferred out 1,000 shares in the company on the 16th May 2013 at a price of 0.00p.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>3 FTSE 100 Shares Hitting New Highs: GlaxoSmithKline plc (GSK), BT Group plc ...</title>
<link>http://www.insidermonkey.com/blog/3-ftse-100-shares-hitting-new-highs-glaxosmithkline-plc-gsk-bt-group-plc-bt-a-british-american-tobacco-plc-bats-140274/</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://www.insidermonkey.com/blog/3-ftse-100-shares-hitting-new-highs-glaxosmithkline-plc-gsk-bt-group-plc-bt-a-british-american-tobacco-plc-bats-140274/</guid>
<pubDate>Mon, 13 May 2013 18:53:28 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/3-ftse-100-shares-hitting-new-highs-glaxosmithkline-plc-gsk-bt-group-plc-bt-a-british-american-tobacco-plc-bats-140274/&quot; style=&quot;font-size:1.2em&quot;&gt;3 FTSE 100 Shares Hitting New Highs: GlaxoSmithKline plc (GSK), BT Group plc ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;GlaxoSmithKline plc Shares in pharmaceuticals giant and Beginners&amp;#39; Portfolio member GlaxoSmithKline plc (LON:GSK) are up nearly 20% over the past 12 months, having hit a 52-week high of 1,692 pence today -- though as I write, the price is back a penny ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>A Closer Look At GlaxoSmithKline Plc&amp;#39;s Dividend Potential</title>
<link>http://www.fool.co.uk/news/investing/2013/05/10/a-closer-look-at-glaxosmithkline-plcs-dividend-pot.aspx</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:43982056591708</guid>
<pubDate>Fri, 10 May 2013 15:37:14 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.fool.co.uk/news/investing/2013/05/10/a-closer-look-at-glaxosmithkline-plcs-dividend-pot.aspx&quot; style=&quot;font-size:1.2em&quot;&gt;A Closer Look At GlaxoSmithKline Plc&amp;#39;s Dividend Potential&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Motley Fool UK&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 10, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Is GlaxoSmithKline plc (LON: GSK) a solid pick for dividend growth? Dividend income accounts for around two-thirds of total returns, the actual rate of return taking into account both capital and income appreciation.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>The City News: Antofagasta plc (ANTO), Rolls-Royce Holding PLC (RR ...</title>
<link>http://www.insidermonkey.com/blog/the-city-news-antofagasta-plc-anto-rolls-royce-holding-plc-rr-glaxosmithkline-plc-gsk-more-140161/</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://www.insidermonkey.com/blog/the-city-news-antofagasta-plc-anto-rolls-royce-holding-plc-rr-glaxosmithkline-plc-gsk-more-140161/</guid>
<pubDate>Mon, 13 May 2013 09:06:49 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/the-city-news-antofagasta-plc-anto-rolls-royce-holding-plc-rr-glaxosmithkline-plc-gsk-more-140161/&quot; style=&quot;font-size:1.2em&quot;&gt;The City News: Antofagasta plc (ANTO), Rolls-Royce Holding PLC (RR ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Editor&amp;#39;s Note: Related tickers: Wal-Mart Stores, Inc. (NYSE:WMT), Tesco Corporation (USA) (NASDAQ:TESO), Goldman Sachs Group, Inc. (NYSE:GS), Virgin Media Inc. (NASDAQ:VMED), BT Group plc (ADR) (NYSE:BT), Theravance Inc (NASDAQ:THRX), ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>GLAXOSMITHKLINE PLC : Transaction in Own Shares</title>
<link>http://www.4-traders.com/GLAXOSMITHKLINE-PLC-9590199/news/GlaxoSmithKline-plc-Transaction-in-Own-Shares-16858124/</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:43982060529908</guid>
<pubDate>Mon, 13 May 2013 17:19:06 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/GLAXOSMITHKLINE-PLC-9590199/news/GlaxoSmithKline-plc-Transaction-in-Own-Shares-16858124/&quot; style=&quot;font-size:1.2em&quot;&gt;GLAXOSMITHKLINE PLC : Transaction in Own Shares&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;GlaxoSmithKline plc (the Company) announces that in accordance with the authority granted by shareholders at the Company&amp;#39;s Annual General Meeting on 1 May 2013 it purchased 297,000 of its Ordinary Shares of 25 pence each (Shares) on 13 May 2013.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK), Elan Corporation ...</title>
<link>http://www.insidermonkey.com/blog/theravance-inc-thrx-glaxosmithkline-plc-adr-gsk-elan-corporation-plc-adr-eln-who-benefits-from-this-market-moving-biotechnology-partnership-141072/</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://www.insidermonkey.com/blog/theravance-inc-thrx-glaxosmithkline-plc-adr-gsk-elan-corporation-plc-adr-eln-who-benefits-from-this-market-moving-biotechnology-partnership-141072/</guid>
<pubDate>Tue, 14 May 2013 14:46:57 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/theravance-inc-thrx-glaxosmithkline-plc-adr-gsk-elan-corporation-plc-adr-eln-who-benefits-from-this-market-moving-biotechnology-partnership-141072/&quot; style=&quot;font-size:1.2em&quot;&gt;Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK), Elan Corporation ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;If we look at just the respiratory segment, which is partnered with GlaxoSmithKline plc (ADR) (NYSE:GSK) and now Elan Corporation, plc (ADR) (NYSE:ELN), Theravance Inc (NASDAQ:THRX) now has one FDA approved product and another near approval.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Earnings: Eli Lilly &amp;amp; Co (LLY), GlaxoSmithKline plc (GSK), Novartis AG - ValueWalk</title>
<link>http://www.valuewalk.com/2013/04/earnings-eli-lilly-co-lly-glaxosmithkline-plc-gsk-novartis-ag/</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:52778130600341</guid>
<pubDate>Wed, 24 Apr 2013 14:52:17 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.valuewalk.com/2013/04/earnings-eli-lilly-co-lly-glaxosmithkline-plc-gsk-novartis-ag/&quot; style=&quot;font-size:1.2em&quot;&gt;Earnings: Eli Lilly &amp;amp; Co (LLY), GlaxoSmithKline plc (GSK), Novartis AG - ValueWalk&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;ValueWalk&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Three of the biggest pharmaceutical companies have announced their earnings today, for the first quarter of 2013. The profits for Eli Lilly &amp;amp; Co.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>GLAXOSMITHKLINE PLC : Breo Ellipta FDA Approval</title>
<link>http://www.4-traders.com/GLAXOSMITHKLINE-PLC-9590199/news/GlaxoSmithKline-plc-Breo-Ellipta-FDA-Approval-16840242/</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://www.4-traders.com/GLAXOSMITHKLINE-PLC-9590199/news/GlaxoSmithKline-plc-Breo-Ellipta-FDA-Approval-16840242/</guid>
<pubDate>Fri, 10 May 2013 17:11:19 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/GLAXOSMITHKLINE-PLC-9590199/news/GlaxoSmithKline-plc-Breo-Ellipta-FDA-Approval-16840242/&quot; style=&quot;font-size:1.2em&quot;&gt;GLAXOSMITHKLINE PLC : Breo Ellipta FDA Approval&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 10, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO?&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>What This Top Dividend Portfolio Is Holding Now: GlaxoSmithKline plc, HSBC ...</title>
<link>http://www.fool.co.uk/news/investing/2013/05/02/what-this-top-dividend-portfolio-is-holding-now-gl.aspx</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://www.fool.co.uk/news/investing/2013/05/02/what-this-top-dividend-portfolio-is-holding-now-gl.aspx</guid>
<pubDate>Thu, 02 May 2013 13:43:36 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.fool.co.uk/news/investing/2013/05/02/what-this-top-dividend-portfolio-is-holding-now-gl.aspx&quot; style=&quot;font-size:1.2em&quot;&gt;What This Top Dividend Portfolio Is Holding Now: GlaxoSmithKline plc, HSBC ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Motley Fool UK&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 2, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;GlaxoSmithKline plc (LON:GSK), HSBC Holdings plc (LON:HSBA) and Vodafone Group plc (LON:VOD) are the heavyweight holdings of Temple Bar Investment Trust PLC (LON:TMPL).&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Is GlaxoSmithKline Plc An Exciting Emerging Market Play?</title>
<link>http://www.fool.co.uk/news/investing/2013/04/30/is-glaxosmithkline-plc-an-exciting-emerging-market.aspx</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:52778139210018</guid>
<pubDate>Tue, 30 Apr 2013 14:23:08 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.fool.co.uk/news/investing/2013/04/30/is-glaxosmithkline-plc-an-exciting-emerging-market.aspx&quot; style=&quot;font-size:1.2em&quot;&gt;Is GlaxoSmithKline Plc An Exciting Emerging Market Play?&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Motley Fool UK&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 30, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Are developing regions set to drive GlaxoSmithKline plc (LON: GSK) higher? While crippling austerity in Europe and fiscal obstacles could put the brake on growth rates there, in developing regions a backdrop of accommodative central bank action ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
